Table 4.
The average IgG/IgM antibody titers according to the disease severity from symptom onset to day 210.
| Days | IgG AU/mL |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Asymptomatic | % | Mild | % | Moderate | % | Severe | % | Critical | % | |
| 30 | 243.7 ± 0 | 148.7 ± 41.6 | 172.7 ± 46.8 | 154.7 ± 59.1 | 170.8 ± 36.6 | |||||
| 60 | 24.2 ± 0 | 9.9 | 95.0 ± 62.7 | 63.9 | 92.6 ± 40.8 | 53.6 | 97.8 ± 38.2 | 63.2 | 109.6 ± 73.8 | 64.2 |
| 90 | 38.6 ± 27.3 | 15.8 | 60.7 ± 32.4 | 40.8 | 61.8 ± 30.0 | 35.8 | 62.8 ± 25.6 | 40.6 | 73.3 ± 33.3 | 43.1 |
| 120 | 39.9 ± 23.3 | 16.4 | 58.4 ± 32.6 | 39.3 | 65.1 ± 28.3 | 37.7 | 72.8 ± 27.6 | 47.1 | 62.4 ± 24.0 | 36.5 |
| 150 | 39.9 ± 10.7 | 16.4 | 51.0 ± 33.0 | 34.3 | 44.0 ± 36.8 | 25.5 | 51.6 ± 20.0 | 33.4 | 64.3 ± 23.5 | 37.6 |
| 180 | 17.7 ± 11.0 | 7.3 | 47.8 ± 28.8 | 32.1 | 24.7 ± 24.7 | 14.3 | 49.1 ± 24.8 | 31.7 | 64.3 ± 23.3 | 37.6 |
| 210 | 21.8 ± 9.1 | 15.1 | 44.5 ± 28.6 | 29.9 | 40.7 ± 24.3 | 23.6 | 48.5 ± 25.1 | 31.4 | 49.1 ± 19.5 | 28.7 |
| IgM AU/mL | ||||||||||
| 30 | 2.9 ± 0 | 50.1 ± 55.4 | 107.8 ± 21.2 | 184.5 ± 231.9 | 60.1 ± 50.1 | |||||
| 60 | 1.1 ± 0 | 59.0 ± 63.3 | 16.7 ± 15.3 | 110.0 ± 127.0 | 19.7 ± 15.9 | |||||
| 90 | 4.0 ± 4.1 | 3.8 ± 3.5 | 9.4 ± 12.3 | 10.7 ± 11.0 | 18.7 ± 18.5 | |||||
| 120 | 2.0 ± 1.6 | 7.8 ± 8.8 | 9.5 ± 9.6 | 18.8 ± 19.6 | 11.6 ± 10.0 | |||||
| 150 | 0.6 ± 0.2 | 10.4 ± 11.8 | 7.0 ± 6.9 | 14.4 ± 15.5 | 15.9 ± 3.0 | |||||
| 180 | 2.1 ± 2.8 | 6.8 ± 9.8 | 4.2 ± 5.2 | 9.5 ± 11.5 | 11.1 ± 8.6 | |||||
| 210 | 0.5 ± 0.1 | 2.9 ± 3.3 | 4.3 ± 5.1 | 6.3 ± 7.4 | 4.4 ± 4.8 | |||||